Santen Pharmaceutical Co. Ltd. ADR

12.510+0.0900+0.72%Vol 53.97K1Y Perf -22.57%
Dec 3rd, 2021 15:53
BID0.0000 ASK0.0000
Open12.450 Previous Close12.420
Pre-Market- After-Market-
 - -  - -%
Target Price
- 
Analyst Rating
— — 0.00
Potential %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
     40.89
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
★+     34.38
Price Range Ratio 52W %
4.96 
Earnings Rating
Market Cap- 
Earnings Date
-
Alpha-0.00 Standard Deviation0.08
Beta0.35 

Today's Price Range

12.44012.586

52W Range

12.27017.113

5 Year PE Ratio Range

9.700038.200

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-6.64%
1 Month
-13.90%
3 Months
-20.22%
6 Months
-5.51%
1 Year
-22.57%
3 Years
-24.41%
5 Years
6.11%
10 Years
0.00%

TickerPriceChg.Chg.%
SNPHY12.5100.09000.72
AAPL161.84-1.9200-1.17
GOOG2 850.41-25.1200-0.87
MSFT323.01-6.4800-1.97
XOM60.89-0.3900-0.64
WFC47.75-1.1600-2.37
JNJ159.382.29001.46
FB306.84-3.5500-1.14
GE92.77-2.4600-2.58
JPM158.29-2.9200-1.81
Earnings HistoryEstimateReportedSurprise %
----
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume53.97K
Shares Outstanding0
Shares Float399.85M
Trades Count110
Dollar Volume674.40K
Avg. Volume48.47K
Avg. Weekly Volume88.57K
Avg. Monthly Volume36.92K
Avg. Quarterly Volume26.73K
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Summary Rating-
0.00
-
0.00
-
0.00

Santen Pharmaceutical Co. Ltd. ADR

Santen Pharmaceutical Co Ltd is a drug manufacturing company that focuses on ophthalmic products. The company reports two primary operating segments: prescription ophthalmic pharmaceuticals and other. The pharmaceuticals segment includes over-the-counter pharmaceuticals, while the other segment includes medical devices. The vast majority of Santen's revenue is derived from its prescription ophthalmic pharmaceuticals segment, which manufactures and distributes prescription and OTC pharmaceuticals. Most of Santen's sales are generated in Japan, followed by other Asian countries.

CEO:

Telephone: +81 663217000

Address: Grand Front Osaka Tower A, Osaka 530-8552, , JPN

Number of employees: 4 073

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

45%55%

Bearish Bullish

43%57%

News